Pulsara Welcomes New Member to Board of Directors
Brian Webster, CEO of Kestra Medical Technologies, brings significant healthcare expertise to Pulsara’s Board of Directors
Interventional approaches to treating stroke involve inserting a clot-removing device into the afflicted vessel to physically grab and remove the blockage. This therapy has shown great promise for stroke patient outcomes and several studies analyzing intervention have been stopped early due to efficacy of the treatment.
Take a look at neurointervention up close and personal - from two different perspectives. Covidien and Stryker are two companies leading the way in intervention with their respective Solitaire and Trevo devices. And since a picture is worth a thousand words, we thought we'd go a step further and show you video of how each actually works inside the brain. Enjoy!
Brian Webster, CEO of Kestra Medical Technologies, brings significant healthcare expertise to Pulsara’s Board of Directors
At Pulsara, our customers are why we do what we do. It's our privilege to help serve the people who serve people, and we're always excited to see...
The mental health of America’s youth is under duress, and it didn’t start with COVID-19. It’s a problem that’s been a much longer time coming. In...